Haemophilia Clinical Trial
Official title:
Nonpharmacological Approach of Chronic Pain in Patients With Hemophilia: a Combined Approach From Psychology and Physiotherapy
NCT number | NCT03529474 |
Other study ID # | 2017/0320 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 14, 2018 |
Est. completion date | March 15, 2019 |
Verified date | June 2019 |
Source | Instituto de Investigacion Sanitaria La Fe |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study evaluates the clinical impact of a combined protocol with cognitive-behavioral intervention and physiotherapy adjuvant to the standard medical treatment in patients with haemophilia that suffer from chronic pain
Status | Completed |
Enrollment | 19 |
Est. completion date | March 15, 2019 |
Est. primary completion date | March 15, 2019 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Diagnosis of haemophilia A or B. - Age between 18 and 60 years. - Informed consent signed. - Signs of arthropathy according to clinical criteria (score Gilbert) and / or radiological criteria (score Pettersson) in at least one of the six joints most commonly affected (ankles, knees or elbows) - Chronic pain (CP) defined as persistent pain lasting at least six months and resistant to conventional medical therapy. It differs from the acute pain not only in its longer duration, but also sometimes persists even after the cause that produced it has disappeared. - Absence of active coping strategies, understanding the concept of coping as those cognitive and behavioral efforts made by the individual in order to manage internal and external demands generated by their chronic pain condition and that involve a challenge to their potential individual resources. Exclusion Criteria: - Presence of inhibitor to FVIII or FIX. - Another haemostatic defect. - Patients with severe cognitive deficits with which it is not possible a cognitive psychological intervention. - The inability to attend physiotherapy sessions for 12 consecutive weeks (7 supervised and 31 self-monitored) - Surgical procedures performed 6 weeks prior or during the intervention protocol. - Not acceptance or withdrawal of informed consent |
Country | Name | City | State |
---|---|---|---|
Spain | Instituto de Investigación Sanitaria La Fe. Hospital Universitari i Politècnic La Fe | Valencia |
Lead Sponsor | Collaborator |
---|---|
Instituto de Investigacion Sanitaria La Fe | Pfizer |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in Perceived Self-efficacy: Chronic Pain Self-Efficacy Scale Spainsh Version. (Martín-Aragon et al., 1999). | The scale contain 3 Subscales: Self-efficacy in the control of symptoms (score 0-80); Self-efficacy in physical functioning (score 0-60) and Self-efficacy in pain management (score 0-50). Total Score: 0-190 and higher values represent a better outcome (more Self-Efficacy perceived). | baseline, 4 months, 7 months | |
Secondary | Quality of Life related with health | Measured by a Specific questionnaire for Quality of Life related with health evaluation for adults with haemophilia (A36Haemophilia-QoL), which explores 9 areas. Subscales and score range: Physical health: 0-32; Daily activities: 0-16; Joints: 0-12; Pain: 0-8; Treatment satisfaction: 0-8; Difficulties treatment: 0-16; Emotional functioning: 0-20; Mental health: 0-12; Social activity: 0-20. Subscales are summed, with a total score from 0-144 and higher values represent a better outcome (more Quality of Life perceived). | baseline, 4 months, 7 months | |
Secondary | Emotional status | Patient's emotional state will be evaluated by Hospital Anxiety and Depression Scale (HAD), which assess the level of anxiety and depression. Subscales and score range are Anxiety (0-21) and Depression (0-21). Scoring: items of each subscale are summed, indicating: 0-7 normality, 8-10 probably case, 11-21 anxiety or depression clinical case. Higher values represent a worse outcome. | baseline, 4 months, 7 months | |
Secondary | Nociceptive pain | Nociceptive pain will be measured by the Visual Analog Scale for pain (VAS) from 0 to 10, where higher values represent a worse outcome. | baseline, 4 months, 7 months | |
Secondary | Neuropathic pain | Neuropathic pain evaluation by Pain Detect Questionnaire (Pain-Detect-Q-Spanish, with a total score 0-38, indicating: 0-12 absence of neuropathic pain; >12-18 doubtful diagnosis and >18-38 presence of neuropathic pain. | baseline, 4 months, 7 months | |
Secondary | Kinesiophobia | Kinesiophobia will be evaluated by Tampa Scale for Kinesiophobia (TSK-11SV) (Spanish adaptation. Gómez-Pérez, López-Martínez y Ruiz-Párraga, 2011). Scoring: Items are summed, with a total score from 11-44 and higher values represent a worse outcome (more pain interference in behavior). | baseline, 4 months, 7 months | |
Secondary | Functional capacity: The Timed "Up & Go" test | Timed "Up & Go" will be used to measure functional capacity. Less time to complete the test in seconds implies better outcome | baseline, 4 months, 7 months | |
Secondary | Functional capacity: Sit-to-stand test | Sit-to-stand test will be used to measure functional capacity. Less time to complete the test in seconds implies better outcome | baseline, 4 months, 7 months | |
Secondary | Functional capacity: 2-minutes walk test | Evaluation of functional capacity during walking by using 2 minutes walk test. More distance covered in 2 minutes implies better outcome. | baseline, 4 months, 7 months | |
Secondary | Self-perceived functional capacity | Impact of haemophilia on self-perceived functional abilities in adults measured by Haemophilia Activities List questionnaire (HAL). It contains 42 multiple choice questions in seven domains (Sum Score: 42-252). Normalized scores for the domains and the full questionnaire can also be obtained, being possible scores range from 0 to 100, where 0 represents the worst possible functional status and 100 the best possible functional status. | baseline, 4 months, 7 months | |
Secondary | Active Range of Movement | A digital goniometer will be used (Digital absolute Axis goniometer, Baseline evaluation instruments, White Plains, USA) for the measurement of active elbow, knee and ankle range of movement. | baseline, 4 months, 7 months | |
Secondary | Joint health status | Joint clinical evaluation of elbows, knees and ankles by using The Hemophilia Joint Health Score 2.1 (HJHS). The full score range goes from 0 to 124 points (0-20 points for each of the six joints evaluated, plus 4 points for the overall assessment of gait. 0 means no joint damage, whereas the higher the value, the higher the degree of arthropathy. | baseline, 4 months, 7 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02229331 -
Biomechanical Determinants and Patterns Associated to the Pathophysiological Cascade of Ankle Arthropathy in Children With Haemophilia: Non-invasive In-vivo Measurement of Foot Joints in Children With Haemophilia During Gait.
|
||
Completed |
NCT02870114 -
National Survey of People With Haemophilia in Portugal
|
N/A | |
Recruiting |
NCT02197611 -
Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia.
|
N/A | |
Unknown status |
NCT02582450 -
Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia
|
N/A | |
Completed |
NCT05138224 -
Prevalence of Autistic Spectrum Disorder (ASD) in Children With Haemophilia
|
||
Recruiting |
NCT03287999 -
Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B
|
||
Completed |
NCT02825667 -
Effectiveness of the Myofascial Therapy in the Hemophilic Arthropathy of Ankle
|
N/A | |
Completed |
NCT03818529 -
ATHN 8: Previously Untreated Patients (PUPs) Matter Study
|
||
Completed |
NCT05108480 -
Self-myofascial Release With Foam Roller in Patients With Hemophilic Knee Arthropathy
|
N/A | |
Completed |
NCT02781233 -
A Progressive Resistance Training Program in Patients With Haemophilia
|
N/A | |
Active, not recruiting |
NCT02581735 -
Effectiveness of the uPatient Platform in Prophylactic Treatment in Hemophilia
|
N/A | |
Active, not recruiting |
NCT02512211 -
Validation of Questionnaires HAL and HEP
|
N/A | |
Not yet recruiting |
NCT01623960 -
Quality of Life in Adult Patients With Severe Haemophilia in Turkey
|
N/A | |
Recruiting |
NCT02191436 -
Adherence to Treatment in Hemophilia
|
N/A | |
Completed |
NCT03264014 -
Combining Registry Data in Haemophilia: TARGET H
|
N/A | |
Recruiting |
NCT02198430 -
Multidisciplinary Evaluation of Patients With Hemophilia
|
N/A | |
Not yet recruiting |
NCT06046235 -
Virtual Evaluations of Joint Health Using Wearable Sensors in Persons With Haemophilia (VESPA)
|
||
Completed |
NCT05425888 -
Functional and Proprioceptive Status in Patients With Hemophilic Ankle Arthropathy
|
||
Recruiting |
NCT03914209 -
Extended Half-Life (EHL) Clotting Factor for Improving the Musculoskeletal Health of Patients With Hemophilia
|
||
Completed |
NCT04205188 -
The Effects of Therapeutic Exercises on Kinesiophobia in Haemophilic Patients.
|
N/A |